LIMN · Liminatus Pharma, Inc.
$0.11
-0.01 (-6.57%)
At close · Jul 24
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“management has concluded that there is substantial doubt about its ability to continue as a going concern for one year after the date that the accompanying unaudited condensed consolidated financial statements are issued.”View the 10-Q filed May 15, 2026
Market Cap
$4.98M
Shares
44.88M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
Key facts
CIK
1971387
CUSIP
53271X108
13F (30d)
3 filings
3 filers